Author

G. Antonelli

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 5 Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 4 Assay:proteomics· 3 Research Focus:cell type annotation· 2 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1

Frequent Co-Authors

I. Paciello· 4 shared C. Sala· 3 shared D. Medini· 3 shared E. Andreano· 3 shared G. Maccari· 3 shared G. Pierleoni· 3 shared P. Pileri· 3 shared R. Rappuoli· 3 shared

Activity by Year

2020-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

I. Paciello

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

B cell maturation restored ancestral germlines to control Omicron BA.2.86

I. Paciello, G. Pierleoni, E. Pantano, G. Antonelli, P. Pileri, G. Maccari, D. Cardamone, G. Realini, F. Perrone, M. M. Neto, S. Pozzessere, M. Fabbiani, F. Panza, I. Rancan, M. Tumbarello, , E. Andreano

The paper analyzes neutralizing antibodies from vaccinated and hybrid immune individuals to show that restored B cell germlines enhance neutralization against SARS-CoV-2 variants like BA.2.86.

bioRxiv · Mar 3, 2024 · PreprintImmunology

Human monoclonal antibodies reveal subdominant gonococcal and meningococcal cross-protective antigens

M. Troisi, M. Fabbrini, S. Stazzoni, V. Viviani, F. Carboni, V. Abbiento, L. E. Fontana, S. Tomei, M. Audagnotto, L. Santini, A. Spagnuolo, G. Antonelli, I. Paciello, F. Vacca, D. Cardamone, , An

The paper identifies human monoclonal antibodies that recognize key antigens, PorB and LOS, providing cross-protection against gonococcal and meningococcal infections.

bioRxiv · Dec 7, 2023 · PreprintImmunology

mRNA vaccines and hybrid immunity use different B cell germlines to neutralize Omicron BA.4 and BA.5

E. Andreano, I. Paciello, G. Pierleoni, G. Maccari, G. Antonelli, V. Abbiento, P. Pileri, L. Benincasa, G. Giglioli, G. Piccini, C. De Santi, C. Sala, D. Medini, E. Montomoli, P. Maes, R. Rappuoli

The paper compares neutralizing antibodies against Omicron BA.4 and BA.5 from mRNA-vaccinated individuals and those with hybrid immunity, finding differences in epitope targeting and B cell germlines used.

bioRxiv · Aug 4, 2022 · PreprintImmunology

COVID-19 mRNA third dose induces a unique hybrid immunity-like antibody response

E. Andreano, I. Paciello, G. Pierleoni, G. Piccini, V. Abbiento, G. Antonelli, P. Pileri, N. Manganaro, E. Pantano, G. Maccari, S. Marchese, L. Donnici, L. Benincasa, G. Giglioli, M. Leonardi, , R. Rappuoli

This study examines how a third mRNA vaccine dose enhances neutralizing antibody responses against SARS-CoV-2 variants by expanding specific B cell germlines and altering the antibody repertoire.

bioRxiv · May 9, 2022 · PreprintImmunology

HIV-1 provirus excised by single CRISPR/Cas9 RNA guide persists in host cell and may be reactivated

M. Lai, E. Maori, P. Quaranta, G. Matteoli, F. Maggi, M. Sgarbanti, S. Crucitta, S. Paci, O. Turriziani, G. Freer, J. L. Heeney, G. Antonelli, M. Pistello

This study shows that HIV-1 provirus excised by CRISPR/Cas9 can persist and be reactivated, highlighting the need for additional antiviral therapy to fully eradicate infection.

bioRxiv · Nov 16, 2020 · PreprintMicrobiology